FENOFIBRIC Drug Patent Profile
✉ Email this page to a colleague
When do Fenofibric patents expire, and what generic alternatives are available?
Fenofibric is a drug marketed by Actavis Elizabeth, Alembic, Aurobindo Pharma Ltd, Chartwell Rx, Impax Labs Inc, Macleods Pharms Ltd, Micro Labs, Ph Health, Pharmobedient, Rising, Twi Pharms, and Yichang Humanwell. and is included in twelve NDAs.
The generic ingredient in FENOFIBRIC is choline fenofibrate. There are one hundred and two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the choline fenofibrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FENOFIBRIC?
- What are the global sales for FENOFIBRIC?
- What is Average Wholesale Price for FENOFIBRIC?
Summary for FENOFIBRIC
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 12 |
| Drug Prices: | Drug price information for FENOFIBRIC |
| DailyMed Link: | FENOFIBRIC at DailyMed |
US Patents and Regulatory Information for FENOFIBRIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 200920-001 | Oct 7, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 200913-002 | Mar 25, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 212562-002 | Dec 23, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 200750-001 | Dec 4, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alembic | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 208705-002 | May 12, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Macleods Pharms Ltd | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 207796-002 | Feb 8, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 211626-002 | Jul 18, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
